The transition to value-based care has been especially slow in the behavioral health sector, which experts blame on a lack of standardized metrics to measure outcomes and technological barriers. Many hope the CMS will take the lead in spurring change.
In the week ahead, regulators will look at ways to curb the opioid crisis and tobacco use.
With unemployment dipping below 4% for the first time since December 2000, employers have their work cut out for them to keep workers happy. Organizations making this year's list of Best Places to Work in Healthcare stand out in their efforts to create an empowered and satisfied workforce.
The Senate Finance Committee believes global budgets would bolster struggling rural healthcare systems.
Blue Cross & Blue Shield of Illinois plans to cut Medicaid reimbursement rates by 35% for medical suppliers—apparently in an effort to win back business after new enrollees were blocked from the state's revamped Medicaid managed-care program.
Hospitals are urging HHS not to delay a rule that would set new ceiling prices for the 340B drug discount program. If the delay happens, 340B providers would be on the hook for high drug costs.
EHR vendor Athenahealth's board of directors is under pressure from Elliott Management to accept the hedge fund's nearly $7 billion cash offer.
HHS officials outlined the agency's priorities, which include driving value-based care and pursuing deregulation.
Eighty percent of nearly 750 providers, payers and pharmaceutical companies polled said they are optimistic that the new health system-led generic-drug company will change the status quo, and 90% said they would buy drugs from it, according to a new survey.
Clinicians should do more to identify premature infants that are at low risk of developing sepsis to prevent unnecessary antibiotic exposure, which has been associated with increased risks of death, according to a new study.
David Cordani doesn't view Cigna as merely a health insurer. The Bloomfield, Conn.-based company, he said, is in the business of delivering "health services." The proposed $54 billion purchase of Express Scripts falls in line with that, he argued.